Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 2
2015 3
2016 6
2017 3
2018 5
2019 7
2020 5
2021 15
2022 6
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hachiya yoshio[Author] (1 results)?
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T. Kawai H, et al. Among authors: yoshio s. Hepatology. 2022 Jul;76(1):112-125. doi: 10.1002/hep.32256. Epub 2021 Dec 22. Hepatology. 2022. PMID: 34855990
Pharmacotherapy options for managing hepatitis B in children.
Komatsu H, Inui A, Yoshio S, Fujisawa T. Komatsu H, et al. Among authors: yoshio s. Expert Opin Pharmacother. 2021 Mar;22(4):449-467. doi: 10.1080/14656566.2020.1841165. Epub 2021 Jan 20. Expert Opin Pharmacother. 2021. PMID: 33090882 Review.
Liver disease secondary to congenital heart disease in children.
Komatsu H, Inui A, Kishiki K, Kawai H, Yoshio S, Osawa Y, Kanto T, Fujisawa T. Komatsu H, et al. Among authors: yoshio s. Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):651-666. doi: 10.1080/17474124.2019.1621746. Epub 2019 May 26. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31131680 Review.
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Yamauchi R, Ito T, Yoshio S, Yamamoto T, Mizuno K, Ishigami M, Kawashima H, Yasuda S, Shimose S, Iwamoto H, Yamazoe T, Mori T, Kakazu E, Kawaguchi T, Toyoda H, Kanto T. Yamauchi R, et al. Among authors: yoshio s. J Gastroenterol. 2023 Jun;58(6):565-574. doi: 10.1007/s00535-023-01985-w. Epub 2023 Mar 30. J Gastroenterol. 2023. PMID: 36991155
66 results